Why Onto Innovation Is A Still A Buy After More Than Doubling In 4 Years

Onto Innovation has returned more than 220% since 2022, sharply outperforming the S&P 500. Q4 revenue was a record, but growth was only 1.1% year over year and gross margin slipped to 46.4%, offsetting the positive cash generation. Advanced packaging and specialty devices now account for over half of revenue, with management targeting a $2 billion run rate through capacity expansion.

Analysis

ONTO is increasingly a levered way to express the semiconductor packaging cycle, but the market is likely underestimating how quickly mix can outrun headline growth. If advanced packaging continues to take share, the company can sustain premium valuation multiples even with muted top-line prints because the real driver is not units but content per wafer and capacity monetization.

The second-order effect is competitive pressure on smaller capital equipment names and outsourced package/test ecosystems: once a customer qualifies ONTO into a packaging node, switching costs rise and the vendor can sit on the critical path for multiple process generations. That said, the current setup is vulnerable to a classic “good business, bad stock” reversal if margin compression persists while revenue growth stays low; in that case, investors may rotate to names with clearer cyclical acceleration rather than structural share gain.

The key risk horizon is 1-2 quarters, not years. The stock has already re-rated sharply, so any evidence that capacity additions are pulling forward expenses faster than revenue or that foundry/OSAT capex budgets are being deferred could hit the multiple first, before fundamentals weaken. Conversely, if management can show the $2B run-rate is being filled by higher-margin packaging programs, the next leg higher could be driven by estimate revisions rather than multiple expansion.

Consensus appears to be treating ONTO as a quality compounder, but the underappreciated question is whether this is still a cyclical equipment name wearing a secular-growth badge. The move may be overdone near term if investors are paying for perfect execution into a period where gross margin has already started to normalize lower, especially since the stock’s recent outperformance leaves less room for disappointment.

Key Decisions for Investors

• Stay tactically long ONTO only on pullbacks over the next 2-6 weeks; use 5-7% trailing stops because the stock’s re-rating makes it sensitive to even small margin or order-book disappointments.
• Pair trade: long ONTO / short a basket of more cyclical semi-cap equipment names over 1-3 months, if you want secular packaging exposure with lower beta to mainstream wafer-fab capex swings.
• For event risk, consider a limited-risk call spread in ONTO into the next quarter print; the upside case is another estimate reset higher if packaging mix and capacity utilization improve, but cap your premium because valuation is already extended.
• If gross margin continues to slip for another quarter, rotate out of ONTO into beneficiaries of packaging capex such as test/assembly supply-chain names; the trade is about avoiding margin compression while staying exposed to the theme.
• Use a short-dated put spread only if management signals the $2B run-rate needs heavy incremental capex or customer qualification delays; that would create a 1-2 quarter earnings de-rate even if the secular story remains intact.